Pegasys and Copegus Product Information
Safety Information
Contact Us
Site Map
Glossary
Search
PEGASYS® (Peginterferon alfa-2a) for Injection
  • About PEGASYS
  • Taking PEGASYS and COPEGUS
  • Treating Hepatitis C
  • Hepatitis C Basics
  • How do I know if I have Hepatitis C?
  • Living With Hepatitis C
  • PEGASYS for Healthcare Providers
Long term and short term success begins here
  • Treatment Options
  • The Treatment Decision
  • The Course of Treatment
  • What Is Successful Treatment?
  • Test Results and What They Mean
  • Support During Treatment
Pegassist Support

Because we know that the best treatment plan goes beyond medication.
Hepatitis C Support: PEGASSIST
The Treatment Decision

The decision to get treatment for hepatitis C is one of the most significant ones you will ever make. Use this tool to prepare a list of questions and concerns you may have and to evaluate your goals for treatment.

Use the table below to indicate which of these benefits is/are most important to you:

My goals for treatment

  Not important to me Somewhat important to me Very important to me Most important to me
Rendering the virus undetectable
Staying strong
Avoiding further liver damage
Getting on with my life
Feeling better
Acting for my long-term health
Possibly reversing liver damage
Meeting this challenge
Taking back control
Best treatments now available
Putting my hep C behind me
Getting treatment before liver damage occurs may mean better results
Continue

Use the table below to indicate which of these benefits is/are most important to you:

My main concerns about treatment

Not a concern of mine Somewhat important to me Very important to me Most important to me
Self-injection/needles
Side effects
Obtaining/storing/managing medication
Treatment not working
Not being able to finish
Cost
Need for support
Questions during treatment
Impact on my life
Not a good time to for me to start
Get Questions

This list is based on your responses to potential benefits and concerns related to hep C treatment. It provides some questions you may want to ask your healthcare provider.

Remember, this is not meant to be a complete list. The decision to treat hep C is an important one, and you should get answers to all your questions.

Facts

You're not alone: it's estimated that more than 4 million Americans have been infected with HCV.

Eighty percent of people with hep C have no signs or symptoms of the disease. In fact, many people experience no symptoms that they are aware of until significant liver damage has occurred.

Seventy percent of people who have chronic hep C infection go on to have chronic liver disease.

Combination therapy using pegylated interferon and ribavirin can render the virus undetectable in up to 5 out of 10 persons with genotype 1 and in up to 8 out of 10 persons with genotypes 2 and 3.

Studies have found that hepatitis C patients who are treated before liver damage occurs may respond better to treatment.

Print this list




THIS SITE INTENDED FOR U.S. AUDIENCES ONLY

For more information about PEGASYS, contact your physician or other healthcare professional.

Photographs used for illustrative purposes.


RocheCopyright © 2002-2008 Hoffmann-La Roche Inc. All rights reserved. Use and access of this site is subject to the terms and conditions as set out in our Legal Statement and Privacy Statement.